23andMe gets FDA green light for cancer risk test
Genetic testing powerhouse 23andMe announced today that it’s officially received the FDA go-ahead to launch a direct-to-consumer testing kit for genes linked to various forms of cancer. The forthcoming kit, which will be made available without a prescription, tests for BRCA1 and BRCA2, which are linked to higher risk of ovarian, break and prostate cancer.
from TechCrunch http://ift.tt/2FXQZSB
via IFTTT
Comments
Post a Comment